NCT06972225View on ClinicalTrials.gov

Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons.

Not yet recruitingOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

December 31, 2035

Study Completion Date

March 31, 2036

Conditions
Coronary Arterial Disease (CAD)Restenosis, CoronaryBifurcation Coronary Disease
Interventions
DEVICE

DEB

Use of DEB to treat coronary lesions

Trial Locations (1)

G1V4G5

IUCPQ, Québec

All Listed Sponsors
lead

Olivier F. Bertrand

OTHER

NCT06972225 - Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons. | Biotech Hunter | Biotech Hunter